D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 46 Citations 9,667 79 World Ranking 12296 National Ranking 184

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • DNA
  • Enzyme

Mutant, Apoptosis, Tumor suppressor gene, Cancer research and Cell culture are her primary areas of study. Her work in Mutant covers topics such as Mutation which are related to areas like Cell biology and DNA. Her Cell biology research is multidisciplinary, incorporating elements of Genetics and Gene expression.

Her biological study spans a wide range of topics, including In vitro, Transfection and In vivo. Her Tumor suppressor gene research incorporates themes from Retinoblastoma, Binding site and Point mutation. Her research in Cancer research intersects with topics in Immunoprecipitation, Lymphoblast, Downregulation and upregulation, Proto-Oncogene Proteins c-mdm2 and Cell cycle.

Her most cited work include:

  • Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound (779 citations)
  • Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. (611 citations)
  • Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. (317 citations)

What are the main themes of her work throughout her whole career to date?

Her main research concerns Cancer research, Apoptosis, Mutant, Cell biology and Cancer. Her studies in Cancer research integrate themes in fields like Cancer cell, Downregulation and upregulation, Mdm2, Signal transduction and Tumor suppressor gene. Her Apoptosis research incorporates elements of Immunology, Cell culture, In vitro and DNA damage.

The concepts of her Mutant study are interwoven with issues in Mutation, Molecular biology, In vivo and Function. Her studies deal with areas such as Gene expression, Suppressor, DNA, Cancer therapy and Regulation of gene expression as well as Cell biology. Her Cancer research includes themes of NKG2D, Innate immune system, Immune system and Photodynamic therapy.

She most often published in these fields:

  • Cancer research (35.59%)
  • Apoptosis (30.51%)
  • Mutant (24.58%)

What were the highlights of her more recent work (between 2013-2020)?

  • Cancer research (35.59%)
  • Cell biology (22.88%)
  • Gene (11.02%)

In recent papers she was focusing on the following fields of study:

Galina Selivanova spends much of her time researching Cancer research, Cell biology, Gene, Apoptosis and Mdm2. The various areas that Galina Selivanova examines in her Cancer research study include Cancer cell, Wild type and DNA repair. Her study in Apoptosis is interdisciplinary in nature, drawing from both Cell and DNA damage.

Galina Selivanova combines subjects such as Suppressor, Cancer, Function and Mechanism of action with her study of Mdm2. Her work in Tumor suppressor gene tackles topics such as Cell culture which are related to areas like Molecular biology. She focuses mostly in the field of In vivo, narrowing it down to topics relating to Mutant and, in certain cases, Clinical trial and Pharmacology.

Between 2013 and 2020, her most popular works were:

  • ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis (131 citations)
  • Pharmacological reactivation of p53 as a strategy to treat cancer. (51 citations)
  • Wild type p53 reactivation: From lab bench to clinic (48 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Enzyme

Her primary scientific interests are in Mdm2, MDMX, Cancer research, Cancer and Programmed cell death. Her Mdm2 research focuses on Function and how it connects with Gene. Her study looks at the relationship between Cancer research and fields such as DNA repair, as well as how they intersect with chemical problems.

Her Programmed cell death study incorporates themes from Oxidative stress and Cell biology. Her Cell biology research is multidisciplinary, incorporating perspectives in Cancer cell, Apoptosis, DNA damage and Synthetic lethality. Her Suppressor study combines topics in areas such as Clinical trial, Mutant, Immune system, Small molecule and Pharmacology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

Vladimir J.N. Bykov;Natalia Issaeva;Alexandre Shilov;Monica Hultcrantz.
Nature Medicine (2002)

1096 Citations

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

Natalia Issaeva;Przemyslaw Bozko;Martin Enge;Marina Protopopova.
Nature Medicine (2004)

874 Citations

Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain.

Galina Selivanova;Violetta Iotsova;Violetta Iotsova;Ismail Okan;Michael Fritsche.
Nature Medicine (1997)

479 Citations

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins

Laszlo Szekely;Galina Selivanova;Kristinn P. Magnusson;George Klein.
Proceedings of the National Academy of Sciences of the United States of America (1993)

394 Citations

Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.

Mariam Grigorian;Susanne Andresen;Eugene Tulchinsky;Marina Kriajevska.
Journal of Biological Chemistry (2001)

375 Citations

p53 binds single stranded DNA ends and catalyzes DNA renaturation and strand transfer

G Bakalkin;T Yakovleva;G Selivanova;K P Magnusson.
Proceedings of the National Academy of Sciences of the United States of America (1994)

365 Citations

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

Dawei Xu;Qian Wang;Astrid Gruber;Magnus Björkholm.
Oncogene (2000)

355 Citations

Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs

Vladimir J. N. Bykov;Natalia Issaeva;Nicole Zache;Alexandre Shilov.
Journal of Biological Chemistry (2005)

244 Citations

p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain

Georgy Bakalkin;Galina Selivanova;Tatjana Yakovleva;Elena Kiseleva.
Nucleic Acids Research (1995)

235 Citations

Reactivation of mutant p53: molecular mechanisms and therapeutic potential.

G Selivanova;K G Wiman.
Oncogene (2007)

220 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Galina Selivanova

Klas G. Wiman

Klas G. Wiman

Karolinska Institute

Publications: 50

David P. Lane

David P. Lane

Karolinska Institute

Publications: 45

Carol Prives

Carol Prives

Columbia University

Publications: 34

Varda Rotter

Varda Rotter

Weizmann Institute of Science

Publications: 24

Wafik S. El-Deiry

Wafik S. El-Deiry

Brown University

Publications: 23

Ygal Haupt

Ygal Haupt

Peter MacCallum Cancer Centre

Publications: 22

Hua Lu

Hua Lu

Tulane University

Publications: 22

Gerry Melino

Gerry Melino

University of Rome Tor Vergata

Publications: 21

Catharina Svanborg

Catharina Svanborg

Lund University

Publications: 20

Curtis C. Harris

Curtis C. Harris

National Institutes of Health

Publications: 20

Giannino Del Sal

Giannino Del Sal

University of Trieste

Publications: 19

Wolfgang Deppert

Wolfgang Deppert

Universität Hamburg

Publications: 19

Pierre Hainaut

Pierre Hainaut

Grenoble Alpes University

Publications: 19

Karen H. Vousden

Karen H. Vousden

The Francis Crick Institute

Publications: 18

Michael A. Resnick

Michael A. Resnick

National Institutes of Health

Publications: 17

Chandra S. Verma

Chandra S. Verma

Agency for Science, Technology and Research

Publications: 17

Trending Scientists

Trevor Mudge

Trevor Mudge

University of Michigan–Ann Arbor

So Young Sohn

So Young Sohn

Yonsei University

Chun’an Tang

Chun’an Tang

Dalian University of Technology

Dennis P. Arnold

Dennis P. Arnold

Queensland University of Technology

Senentxu Lanceros-Méndez

Senentxu Lanceros-Méndez

Basque Center for Materials, Applications and Nanostructures

Tsuyoshi Ohnishi

Tsuyoshi Ohnishi

National Institute for Materials Science

Duk Young Jeon

Duk Young Jeon

Korea Advanced Institute of Science and Technology

Leszek Rychlewski

Leszek Rychlewski

BioInfoBank Institute

David E. Salt

David E. Salt

University of Nottingham

Carl E. Stafstrom

Carl E. Stafstrom

Johns Hopkins University School of Medicine

Randy A. Sansone

Randy A. Sansone

Wright State University

Justin T. Pickett

Justin T. Pickett

University at Albany, State University of New York

Alice E. Shapley

Alice E. Shapley

University of California, Los Angeles

Frank Verstraete

Frank Verstraete

Ghent University

Something went wrong. Please try again later.